Search research articles
Contact Us
Filters
Showing results (31-40 of 203) with videos related to
Page
of 21
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
September 30, 1995
[Antithrombotic therapy in cerebrovascular disorders]
T Dahl, U Abildgaard
Critical Reviews in Oncology/Hematology
|
November 1, 1992
Evaluation of nephrotoxicity secondary to cytostatic agents
G Daugaard, U Abildgaard
Scandinavian Journal of Clinical and Laboratory Investigation
|
October 1, 1971
Studies on soluble fibrin in plasma. I. N-terminal analysis of a modified fraction I (Cohn) from normal and thrombin-incubated plasma
P Kierulf, U Abildgaard
Thrombosis and Haemostasis
|
June 30, 1976
On the value of the activated partial thrombo-plastin time (aptt) in monitoring heparin therapy
A N Teien, U Abildgaard
Haemostasis
|
January 1, 1991
Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin
P M Sandset, U Abildgaard
Thrombosis Research
|
September 15, 1984
Assay of unfractionated and LMW heparin with chromogenic substrates: twin methods with factor Xa and thrombin
G F Handeland, U Abildgaard
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
January 10, 1983
[Antithrombin deficiency. Diagnosis and treatment]
U Abildgaard, O R Odegaard
Journal of Internal Medicine
|
November 23, 2006
Bleeding in patients with mechanical heart valves on warfarin: impact of target INR and of comorbidity
A M Njaastad, U Abildgaard
Thrombosis Research
|
August 1, 1984
Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma
U Abildgaard, M L Larsen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
August 20, 1996
[Clexane (enoxaparin) or Fragmin (dalteparin) as thrombolytics in hip surgery? Is Fragmin better than Clexane?]
U Abildgaard, P M Sandset
Page
of 21
Search research articles
Search
Showing results (31-40 of 203) with videos related to
Sort By:
Page
of 21
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
September 30, 1995
[Antithrombotic therapy in cerebrovascular disorders]
T Dahl, U Abildgaard
Critical Reviews in Oncology/Hematology
|
November 1, 1992
Evaluation of nephrotoxicity secondary to cytostatic agents
G Daugaard, U Abildgaard
Scandinavian Journal of Clinical and Laboratory Investigation
|
October 1, 1971
Studies on soluble fibrin in plasma. I. N-terminal analysis of a modified fraction I (Cohn) from normal and thrombin-incubated plasma
P Kierulf, U Abildgaard
Thrombosis and Haemostasis
|
June 30, 1976
On the value of the activated partial thrombo-plastin time (aptt) in monitoring heparin therapy
A N Teien, U Abildgaard
Haemostasis
|
January 1, 1991
Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin
P M Sandset, U Abildgaard
Thrombosis Research
|
September 15, 1984
Assay of unfractionated and LMW heparin with chromogenic substrates: twin methods with factor Xa and thrombin
G F Handeland, U Abildgaard
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
January 10, 1983
[Antithrombin deficiency. Diagnosis and treatment]
U Abildgaard, O R Odegaard
Journal of Internal Medicine
|
November 23, 2006
Bleeding in patients with mechanical heart valves on warfarin: impact of target INR and of comorbidity
A M Njaastad, U Abildgaard
Thrombosis Research
|
August 1, 1984
Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma
U Abildgaard, M L Larsen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
August 20, 1996
[Clexane (enoxaparin) or Fragmin (dalteparin) as thrombolytics in hip surgery? Is Fragmin better than Clexane?]
U Abildgaard, P M Sandset
Page
of 21